Total intraglandular and index tumor volumes predict biochemical recurrence in prostate cancer

被引:8
作者
Shin, Su-Jin [1 ]
Park, Cheol Keun [1 ]
Park, Sung Yoon [2 ]
Jang, Won Sik [3 ]
Lee, Joo Yong [3 ]
Choi, Young Deuk [3 ]
Cho, Nam Hoon [1 ,4 ,5 ]
机构
[1] Yonsei Univ, Coll Med, Dept Pathol, Yonsei Ro 50-1, Seoul 03722, South Korea
[2] Yonsei Univ, Coll Med, Dept Radiol, Yonsei Ro 50-1, Seoul 03722, South Korea
[3] Yonsei Univ, Coll Med, Dept Urol, Yonsei Ro 50-1, Seoul 03722, South Korea
[4] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Yonsei Ro 50-1, Seoul 03722, South Korea
[5] Yonsei Univ, Coll Med, SBSI, Yonsei Ro 50-1, Seoul 03722, South Korea
关键词
Prostatic neoplasms; Recurrence; Tumor burden; Neoplasm grading; ISUP CONSENSUS CONFERENCE; INDEPENDENT PROGNOSTIC-FACTOR; RADICAL PROSTATECTOMY; INTERNATIONAL-SOCIETY; ANTIGEN RECURRENCE; CARCINOMA; SPECIMENS; GRADE; DIAGNOSIS; DIAMETER;
D O I
10.1007/s00428-016-1971-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Prognostic value of tumor volume for biochemical recurrence of prostate cancer remains controversial. We aimed to determine which tumor volume definition would optimally correlate with established prognostic factors and classify macroscopic tumor configuration. Radical prostatectomy specimens with follow-up to biochemical recurrence in the period between 2009 and 2012 were retrieved. Newly proposed categories of reconstructed three-dimensional macroscopic tumor configuration were nodular, medial prominence, subcapsular spreading, and miliary types. Several algorithms were applied to identify optimal tumor volume including (1) combined volume of all nodules, (2) volume of largest nodule as index tumor, and (3) volume of nodule with strongest evidence of poor prognosis. Macroscopic typing correlated well with radiologic findings, and nodular type was most common (70.7 %). In most multifocal tumors, the largest nodule showed the highest Gleason score (90.8 %) as well as extraprostatic extension or seminal vesicle invasion (93.5 %). Total tumor and index tumor volumes were significant predictors of biochemical recurrence (both, P < 0.0001). Tumor volume, classified in three groups with cutoff values at 2 and 5 cm(3), was independently predictive of recurrence-free survival in multivariate analysis (P < 0.05) and surpassed bilaterality even in stage pT2. In pT2 disease, recurrence-free survival was significantly associated with total tumor volume (P = 0.003) and index tumor volume (P = 0.002), but not with pT2 substage (P = 0.278). The proposed macroscopic classification system can be correlated with preoperative imaging findings. Total tumor or index tumor volume significantly predicts biochemical recurrence. Tumor volume classification is easy to apply in practice with high reproducibility and offsets the limitations of pT classification.
引用
收藏
页码:305 / 312
页数:8
相关论文
共 50 条
  • [21] Biochemical recurrence of prostate cancer: the controversial recognition and management
    Xia Shu-jie
    Jing Yi-feng
    [J]. CHINESE MEDICAL JOURNAL, 2011, 124 (09) : 1283 - 1285
  • [22] Construction of a cuproptosis-related lncRNA signature to predict biochemical recurrence of prostate cancer
    Yu, Zhaojun
    Deng, Huanhuan
    Chao, Haichao
    Song, Zhen
    Zeng, Tao
    [J]. ONCOLOGY LETTERS, 2024, 28 (05)
  • [23] External Validation of an MRI-Derived Radiomics Model to Predict Biochemical Recurrence after Surgery for High-Risk Prostate Cancer
    Bourbonne, Vincent
    Fournier, Georges
    Vallieres, Martin
    Lucia, Francois
    Doucet, Laurent
    Tissot, Valentin
    Cuvelier, Gilles
    Hue, Stephane
    Du, Henri Le Penn
    Perdriel, Luc
    Bertrand, Nicolas
    Staroz, Frederic
    Visvikis, Dimitris
    Pradier, Olivier
    Hatt, Mathieu
    Schick, Ulrike
    [J]. CANCERS, 2020, 12 (04)
  • [24] T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence
    Duenweg, Savannah R.
    Bobholz, Samuel A.
    Barrett, Michael J.
    Lowman, Allison K.
    Winiarz, Aleksandra
    Nath, Biprojit
    Stebbins, Margaret
    Bukowy, John
    Iczkowski, Kenneth A.
    Jacobsohn, Kenneth M.
    Vincent-Sheldon, Stephanie
    Laviolette, Peter S.
    [J]. CANCERS, 2023, 15 (18)
  • [25] Genetic risk score to predict biochemical recurrence after radical prostatectomy in prostate cancer: prospective cohort study
    Oh, Jong Jin
    Park, Seunghyun
    Lee, Sang Eun
    Hong, Sung Kyu
    Lee, Sangchul
    Kim, Tae Jin
    Lee, In Jae
    Ho, Jin-Nyoung
    Yoon, Sungroh
    Byun, Seok-Soo
    [J]. ONCOTARGET, 2017, 8 (44) : 75979 - 75988
  • [26] SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy
    Fei Li
    Yong Xu
    Ran-Lu Liu
    [J]. International Urology and Nephrology, 2019, 51 : 443 - 451
  • [27] SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy
    Li, Fei
    Xu, Yong
    Liu, Ran-Lu
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (03) : 443 - 451
  • [28] Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer
    Song, Cheryn
    Kang, Taejin
    Yoo, Sangjun
    Jeong, In Gab
    Ro, Jae Y.
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (02) : 168 - 174
  • [29] miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression
    Fendler, Annika
    Jung, Monika
    Stephan, Carsten
    Honey, Richardson J.
    Stewart, Robert J.
    Pace, Kenneth T.
    Erbersdobler, Andreas
    Samaan, Sara
    Jung, Klaus
    Yousef, George M.
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (05) : 1183 - 1192
  • [30] Validation of the Prostate Cancer Risk Index (PRIX): A Simple Scoring System to Predict Risk of Biochemical Relapse after Radical Prostatectomy for Prostate Cancer
    Yoshida, Takahiro
    Nakayama, Masashi
    Matsuzaki, Kyosuke
    Kobayashi, Yasuyuki
    Takeda, Ken
    Arai, Yasuyuki
    Kakimoto, Ken-ichi
    Nishimura, Kazuo
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (11) : 1271 - 1276